•
Jun 30, 2023

CME Group Q2 2023 Earnings Report

CME Group reported double-digit growth in revenue and adjusted earnings per share for Q2 2023.

Key Takeaways

CME Group reported a 10% increase in revenue and a 17% rise in adjusted earnings per share in Q2 2023, driven by ongoing uncertainty in macroeconomic and geopolitical environments.

Revenue increased by 10% compared to the previous year.

Adjusted earnings per share rose by 17%, marking the eighth consecutive quarter of double-digit earnings growth.

Average daily volume (ADV) was 22.9 million contracts.

Non-U.S. ADV reached 6.3 million contracts, with double-digit year-over-year growth in Agricultural, Metals, and Energy products.

Total Revenue
$1.36B
Previous year: $1.24B
+9.9%
EPS
$2.3
Previous year: $1.97
+16.8%
Average Daily Volume
22.86M
Previous year: 23.1M
-1.1%
Average Rate Per Contract
$0.724
Previous year: $0.647
+11.9%
Gross Profit
$1.15B
Previous year: $1.05B
+9.8%
Cash and Equivalents
$1.88B
Previous year: $1.88B
+0.0%
Free Cash Flow
$630M
Previous year: $600M
+5.0%
Total Assets
$151B
Previous year: $177B
-14.4%

CME Group

CME Group

CME Group Revenue by Segment

Forward Guidance

CME Group will remain focused on delivering value to clients by helping them navigate through what has become an increasingly unpredictable world.

Revenue & Expenses

Visualization of income flow from segment revenue to net income